Vertaling van "interdepartmental committee of experts " (Nederlands → Frans) :

Interdepartmental committee of experts on blood, organs, ICVV – CICSA cells, tissues and embryos (with FPS Public Health, KCE, RIZIV Influenza (in cooperation with external partners)
Interdepartmental committee of experts on blood, organs, ICVV – CICSA cells, tissues and embryos (with FPS Public Health, KCE, RIZIV Influenza (in cooperation with external partners)

Interdepartmental committee of experts on blood, organs,
Interdepartmental committee of experts on blood, organs,

BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council
BAPCOC (with FPS Public Health) Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Interdepartmental network on “information society services” (with FPS Economy) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI) Working group on blood of the Belgian Federal Supreme Health Council Working group on cells, tissues and organs of the Belgian Federal Supreme Health Council

Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)
Consultation platform with FAVV - AFSCA, FPS Public Health and Public Health Minister’s Office DGO - SCM guidance committee (with APB and OPHACO) e-MED (electronic prescription of medicines) (with FPS Public Health and RIZIV - INAMI) “Grey area” consultation platform (with FPS Public Health and FAVV - AFSCA) Guidance committee of the network of medicalpharmaceutical committees ICVV – CICSA Influenza (in cooperation with external partners) Interdepartmental committee of experts on blood, organs, cells, tissues and embryos (with FPS Public Health, KCE, RIZIV - INAMI and WIV - ISP) Inter DG drugs (with FPS Public Health) Mdeon board of management Potassium iodide tablets campaign (with FPS Interior Affairs) Provincial medical commissions (with FPS Public Health) Strategic unit/RIZIV – INAMI Unavailability of medicines (with RIZIV - INAMI)

Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:
Furthermore an expert committee, the Committee for Advanced Therapies (CAT), was A transversal working group has been established within the FAMHP which is responsible for the coordination of this matter and the introduction of the new regulations in practice. This consultation process arrived at the following decisions:

De link met de activiteiten van het Committee on Herbal Medicinal Products (HMPC) via de voorbereiding van de monografieën door de experts en de opvolging van het dossier betreffende gezondheidsbeweringen.
Le lien avec les activités du Committee on Herbal Medicinal Products (HMPC) via la préparation des monographies par les experts, le suivi du dossier relatif aux allégations de santé.

Study on Bacteria Standards (Transfusion-Relevant Bacterial Strain Panel) and Proposal for a validation study for enlargement of the transfusion-relevant bacterial strain panel. Geneva:WHO-Expert Committee on Biological Standardization; 2010. WHO/BS/10.2154.
Geneva:WHO-Expert Committee on Biological Standardization; 2010. WHO/BS/10.2154.

Op basis van de maximumwaarden voor residuen die worden vastgesteld in de producten van dieren die volgens de goede veterinaire praktijken met diclazuril werden behandeld, heeft het « joint FAO/WHO expert committee on Food Additives » voor gevogelte de volgende voorlopige maximumwaarden voor residuen aanbevolen : 500 µg/kg voor de spieren, 3000 µg/kg voor de lever, 2000 µg/kg voor de nieren en 1000 µg/kg voor vet/vel.
Sur base des valeurs maximales en résidus observées dans les produits des animaux traités avec du diclazuril suivant les bonnes pratiques vétérinaires, le Comité d’experts « joint FAO/WHO on Food Additives » a recommandé des limites maximales en résidus provisoires pour les volailles de 500 µg/kg pour les muscles, 3000 µg/kg pour le foie, 2000 µg/kg pour les reins et 1000 µg/kg pour la graisse/peau.

Voor stoffen waarvoor geen ADI is vastgesteld door de Europese Unie, zijn de gegevens afkomstig van het JECFA (Joint FAO/WHO Expert Committee on Food Additives) of van de FDA (U.S. – Food and Drug Administration).
Pour les substances dont la DJA n’a pas été établie au niveau européen, les données proviennent du JECFA (Joint FAO/WHO Expert Committee on Food Additives) ou de la FDA (U.S. – Food and Drug Administration).

The Scientific Committee will work with to experts from the various departments and services in the Agency in order to realise these activities.
The Scientific Committee will work with to experts from the various departments and services in the Agency in order to realise these activities.